Immunohistochemistry assay showed that SPRY4 and E-cadherin were reduced in the pLenti-miR-411 tumor tissues, whereas Ki67 and N-cadherin showed the reverse (Fig. 9f). This evidence concerns the gene CDH2 and neoplasm.